Group 1 - The core viewpoint of the articles highlights the performance of Meili Tianyuan Medical Health, which saw a significant stock price increase of 9.06% despite a recent monthly decline of 7.45% [1][2] - As of August 14, the Hang Seng Index fell by 0.37%, closing at 25,519.32 points, while Meili Tianyuan Medical Health's stock closed at 30.08 HKD per share with a trading volume of 1.1356 million shares and a turnover of 33.8276 million HKD [1] - Financial data for Meili Tianyuan Medical Health shows total revenue of 2.572 billion CNY for the year ending December 31, 2024, representing a year-on-year growth of 19.91%, and a net profit of 228 million CNY, up 5.94% [1] Group 2 - Guohai Securities Co., Ltd. has given a "Buy" rating for Meili Tianyuan Medical Health, indicating positive sentiment towards the company's stock [2] - The average price-to-earnings (P/E) ratio for the healthcare equipment and services industry is 0.68 times, with a median of 1.38 times, while Meili Tianyuan Medical Health has a P/E ratio of 26.35 times, ranking 31st in the industry [2] - Meili Tianyuan Medical Health was established in 1993 and is one of the long-standing domestic chain brands in China's beauty and health management service industry, with a service network covering 352 stores, including 177 direct-operated and 175 franchised stores [2]
美丽田园医疗健康（02373.HK）8月14日收盘上涨9.06%，成交3382.76万港元